Home › NDC Lookup › RxCUI directory › RxCUI 197795

Hydroquinone 40 MG/ML Topical Cream — RxCUI 197795

RxNorm drug concept · Semantic clinical drug
RxCUI 197795 Semantic clinical drug · SCD ● Current RxNorm concept 25 FDA products 25 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197795
Official nameHydroquinone 40 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashydroquinone 4 % Topical Cream
FDA products mapped25
Package NDCs mapped25
Reported Medicaid activity (SDUD)2,440 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Hydroquinone 40 MG/ML Topical Cream Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydroquinone 40 MG/ML Topical Cream RxCUI 197795

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Hydroquinone 5509
  2. Brand names 3

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • EpiQuin Micro 405048
    • Lustra 218118
    • Remergent HQ 688145
  3. Dose forms 10

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydroquinone Topical Cream 377901
    • Hydroquinone Topical Product 1160103
    • Hydroquinone Topical Cream [EpiQuin Micro] 405972
    • Hydroquinone Topical Cream [Lustra] 362248
    • Hydroquinone Topical Cream [Remergent HQ] 688210
    • EpiQuin Micro Topical Product 1167604
    • Lustra Topical Product 1181507
    • Remergent HQ Topical Product 1180722
    • +2 more in this family
  4. Clinical & branded drugs 7

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Hydroquinone 40 MG/ML 329851
    • Hydroquinone 40 MG/ML Topical Cream [EpiQuin Micro] 404047
    • Hydroquinone 40 MG/ML Topical Cream [Lustra] 206612
    • Hydroquinone 40 MG/ML Topical Cream [Remergent HQ] 688211
    • Hydroquinone 40 MG/ML [EpiQuin Micro] 576140
    • Hydroquinone 40 MG/ML [Lustra] 567436
    • Hydroquinone 40 MG/ML [Remergent HQ] 688209

Showing up to 8 concepts per family — 19 of 21 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydroquinone 40 MG/ML SCDC · 329851
  • Hydroquinone Topical Cream SCDF · 377901
  • Hydroquinone Topical Product SCDG · 1160103

Brand-Name Concepts

  • Hydroquinone 40 MG/ML Topical Cream [EpiQuin Micro] SBD · 404047
  • Hydroquinone 40 MG/ML Topical Cream [Lustra] SBD · 206612
  • Hydroquinone 40 MG/ML Topical Cream [Remergent HQ] SBD · 688211
  • Hydroquinone 40 MG/ML [EpiQuin Micro] SBDC · 576140
  • Hydroquinone 40 MG/ML [Lustra] SBDC · 567436
  • Hydroquinone 40 MG/ML [Remergent HQ] SBDC · 688209
  • Hydroquinone Topical Cream [EpiQuin Micro] SBDF · 405972
  • Hydroquinone Topical Cream [Lustra] SBDF · 362248
  • Hydroquinone Topical Cream [Remergent HQ] SBDF · 688210
  • EpiQuin Micro Topical Product SBDG · 1167604

📦 FDA Products & Package NDCs

25 products · 25 package NDCs
25 package NDCs map to RxCUI 197795 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10135-0724-99 1 TUBE in 1 CARTON (10135-724-99) / 28.35 g in 1 TUBE hydroquinone Marlex Pharmaceuticals, Inc. 2021-03-01
24689-0101-01 1 TUBE in 1 CARTON (24689-101-01) / 28.35 g in 1 TUBE Hydroquinone cream APNAR PHARMA LP 2021-11-01
50405-0800-01 1 TUBE in 1 CARTON (50405-800-01) / 28.35 g in 1 TUBE Hydroquinone 4% SOHM, Inc. 2023-06-05
62032-0100-10 28 g in 1 BOTTLE, PLASTIC (62032-100-10) NU-DERM BLENDER Skin Lightener and Blending Obagi Cosmeceuticals LLC 1988-01-01
62032-0100-36 57 g in 1 BOTTLE, PLASTIC (62032-100-36) NU-DERM BLENDER Skin Lightener and Blending Obagi Cosmeceuticals LLC 1988-01-01
62032-0101-36 57 g in 1 BOTTLE, PLASTIC (62032-101-36) NU-DERM CLEAR Skin Bleaching and Corrector Obagi Cosmeceuticals LLC 1988-01-01
62032-0105-36 57 g in 1 BOTTLE, PLASTIC (62032-105-36) Obagi-C Rx system C-Therapy Night Skin Lightening with Vitamins C and E Obagi Cosmeceuticals LLC 2010-01-01
62032-0116-36 57 g in 1 BOTTLE, PLASTIC (62032-116-36) NU-DERM SUNFADER Skin Lightener with Sunscreen (SPF 15) PABA FREE Obagi Cosmeceuticals LLC 1984-01-01
62032-0529-06 1 KIT in 1 CARTON (62032-529-06) * 57 g in 1 BOTTLE, PLAST... nu-derm system normal-dry skin transformation OBAGI COSMECEUTICAL LLC 2019-12-02
62032-0531-00 1 KIT in 1 CARTON (62032-531-00) * 57 g in 1 BOTTLE, PLAST... NU-DERM System NORMAL-Oily SKIN TRANSFORMATION OBAGI COSMECEUTICAL LLC 2019-12-02
62032-0532-07 1 KIT in 1 CARTON (62032-532-07) * 59 mL in 1 BOTTLE, PLAS... NU-DERM system NORMAL-DRY SKIN TRANSFORMATION TRIAL OBAGI COSMECEUTICAL LLC 2019-12-02
62032-0533-60 1 KIT in 1 KIT (62032-533-60) * 59 mL in 1 BOTTLE, PLASTIC... NU-DERM system NORMAL-oily SKIN TRANSFORMATION TRIAL OBAGI COSMECEUTICAL LLC 2019-12-02
62032-0911-01 1 KIT in 1 CARTON (62032-911-01) * 48 g in 1 BOTTLE, PLAST... Obagi Nu-Derm System Normal-Dry Skin Transformation Kit Obagi Cosmeceuticals LLC 2021-06-25
62032-0912-01 1 KIT in 1 CARTON (62032-912-01) * 57 g in 1 BOTTLE, PLAST... Obagi Nu-Derm System Normal-Oily Skin Transformation Obagi Cosmeceuticals LLC 2021-06-25
62032-0914-01 1 KIT in 1 KIT (62032-914-01) * 57 g in 1 BOTTLE, PLASTIC... Obagi Nu-Derm System Normal-Oily Skin Transformation Trial Obagi Cosmeceuticals LLC 2021-06-25
62032-0915-01 1 KIT in 1 KIT (62032-915-01) * 177 mL in 1 BOTTLE, PLASTI... Obagi-C C-Rx System Normal-Oily Skin Intervention Obagi Cosmeceuticals LLC 2021-06-25
62032-0916-01 1 KIT in 1 CARTON (62032-916-01) * 1 TUBE in 1 CARTON (620... Obagi-C C-Rx System Normal-Dry Skin Intervention Obagi Cosmeceuticals LLC 2021-06-25
62032-0918-01 1 KIT in 1 BAG (62032-918-01) * 57 g in 1 BOTTLE, PLASTIC... Obagi Nu-Derm System Normal-Dry Skin Transformation Obagi Cosmeceuticals LLC 2025-06-25
62032-0919-01 1 KIT in 1 BAG (62032-919-01) * 1 TUBE in 1 CARTON (62032-... Obagi Nu-Derm System Normal-Oily Skin Transformation Obagi Cosmeceuticals LLC 2025-06-25
62032-0922-01 1 KIT in 1 BAG (62032-922-01) * 1 TUBE in 1 CARTON (62032-... Obagi-C C-Rx System Normal-Dry Skin Intervention Obagi Cosmeceuticals LLC 2025-06-25
62032-0923-01 1 KIT in 1 BAG (62032-923-01) * 198 mL in 1 BOTTLE, PLASTI... Obagi-C C-Rx system Normal-oily skin Intervention Obagi Cosmeceuticals LLC 2025-06-25
69367-0174-01 1 TUBE in 1 CARTON (69367-174-01) / 28.35 g in 1 TUBE Hydroquinone Westminster Pharmaceuticals, LLC 2018-04-16
71399-0400-01 28.35 g in 1 TUBE (71399-0400-1) HYDROQUINONE 4% Akron Pharma Inc 2024-09-13
72162-2422-02 1 TUBE in 1 CARTON (72162-2422-2) / 28.4 g in 1 TUBE Hydroquinone 4% Bryant Ranch Prepack 2022-08-17
75834-0137-01 1 TUBE in 1 CARTON (75834-137-01) / 28.4 g in 1 TUBE Hydroquinone 4% Nivagen Pharmaceuticals, Inc. 2022-08-17
Observed labelers: Obagi Cosmeceuticals LLC (14) · OBAGI COSMECEUTICAL LLC (4) · Akron Pharma Inc (1) · APNAR PHARMA LP (1) · Bryant Ranch Prepack (1) · Marlex Pharmaceuticals, Inc. (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.